In Clemens v. DaimlerChrysler Corp., 534 F.3d 1017 (ninth Cir. 2008), the courtroom, making use of California legislation, appropriately “decline[d plaintiff’s] invitation to create a brand new exception” to that state’s privity requirement “that may allow [plaintiff’s] motion to proceed.” Id. at 1023-24. “[A] federal courtroom sitting in range will not be free to create new exceptions” to state legislation limiting legal responsibility. Id. at 1024 (citing Day & Zimmermann, Inc. v. Challoner, 423 U.S. 3, 4 (1975)). D&Z held, as we’ve mentioned many instances:
A federal courtroom in a range case will not be free to engraft onto these state guidelines exceptions or modifications which can commend themselves to the federal courtroom, however which haven’t recommended themselves to the State during which the federal courtroom sits.
423 U.S. at 4. And the Supreme Court docket has saved on saying this. Erie ideas prohibit “federal judges” from “displac[ing] the state legislation that may ordinarily govern with their very own guidelines.” Boyle v. United Applied sciences Corp., 487 U.S. 500, 517 (1988). “[A] federal courtroom will not be free to use a special rule nonetheless fascinating it could consider it to be, and although it could assume that the state Supreme Court docket might set up a special rule in some future litigation.” Hicks v. Feiock, 485 U.S. 624, 630 n.3 (1988).
However when updating the realized middleman part of his treatise, Bexis got here throughout a peculiar MDL holding, that as a result of a defendant supposedly “cite[d] no instances” for the proposition “that the realized middleman doctrine ought to apply to Plaintiffs’ . . . shopper safety claims” beneath the legal guidelines of California, Maryland, Illinois, and Florida, then “the realized middleman doctrine mustn’t apply” to claims introduced by plaintiffs in any of those states. In re Natera Prenatal Testing Litigation, 664 F. Supp.3d 995, 1007-08 (N.D. Cal. 2023). The choice didn’t cite any precedent from any of those states (not even a trial courtroom determination) affirmatively creating any exception to the realized middleman rule for shopper fraud claims. Id.
Thus, this MDL determination did precisely what the Ninth Circuit rejected in Clemens – “create[d] a brand new exception” to California’s well-established realized middleman rule. How properly established? See our submit right here, discussing Himes v. Somatics, LLC, 549 P.3d 916 (Cal. 2024), which reaffirmed:
The realized middleman doctrine offers that producers have an obligation to warn physicians, however not the physicians’ sufferers, about sure dangers accompanying use of their prescribed drugs and lots of medical units. The producer needn’t warn of dangers which can be merely speculative or conjectural, or so distant and insignificant as to be negligible. Nor should the producer warn of dangers which can be already identified to the medical group. However the producer is required to warn physicians of any non-negligible dangers which can be usually unknown to the medical group, as this may permit the health-care supplier, and thereby the affected person, to make an knowledgeable selection whether or not to make the most of the drug or medical gadget. As soon as the producer has fulfilled its responsibility to warn the doctor of non-negligible dangers, the responsibility then devolves on the health-care supplier to produce to the affected person such data as is deemed acceptable beneath the circumstances in order that the affected person could make an knowledgeable selection as to remedy.
Id. at 922 (quite a few citations and citation marks omitted).
Furthermore, the overwhelming majority of courts nationwide has held that the realized middleman rule applies to claims introduced beneath state shopper safety statutes. Listed below are the instances from Bexis’ e book that achieve this. We begin with the Texas Supreme Court docket in Centocor, Inc. v. Hamilton, 372 S.W.3d 140, (Tex. 2012), refusing to let plaintiffs keep away from the realized middleman rule through the use of the Texas shopper statute (“DTPA”) as a foundation for difficult physician-directed labeling, discovering “persuasive” the next reasoning:
The gravamen of all of Plaintiffs’ causes of motion, together with misrepresentation and violation of the DTPA, is that the prescription drug producer did not adequately warn of or disclose the severity of [its product’s] unwanted effects. Subsequently, the realized middleman doctrine applies to all of Plaintiffs’ causes of motion. Moreover, whether or not the failure to warn is couched as an affirmative misrepresentation or a misrepresentation by concealment, the allegation collapses right into a cost that the drug producer did not warn. If the doctrine may very well be prevented by casting what is actually a failure to warn declare beneath a special reason behind motion similar to violation of the DTPA or a declare for misrepresentation, then the doctrine can be rendered meaningless.
Id. at 168 (quoting and following In re Norplant Contraceptive Merchandise Legal responsibility Litigation, 955 F. Supp. 700, 709 (E.D. Tex. 1997), aff’d, 165 F.3d 374 (fifth Cir. 1999)); see Wyeth-Ayerst Laboratories Co. v. Medrano, 28 S.W.3d 87, 94 (Tex. App. 2000) (reaching similar end result earlier than Hamilton). A second state excessive courtroom held
[W]e are merely not satisfied {that a} causal connection exists inside the context of prescription drug purchases. Prescription drug instances usually are not the kind of personal causes of motion contemplated beneath the phrases and functions of the [West Virginia consumer protection statute] as a result of the patron cannot and doesn’t determine what product to buy.
White v. Wyeth, 705 S.E.2nd 828, 837-38 (W. Va. 2010)
The requirement that physicians make knowledgeable selections on behalf of every of their sufferers doomed class certification of California shopper safety claims in In re Vioxx Class Instances, 180 Cal. App.4th 116, 134, 103 Cal. Rptr.3d 83 (Cal. App. 2009):
[T]he cardiovascular dangers of [the drug] weren’t materials for all sufferers. Some sufferers would nonetheless take [it] at the moment if it have been available on the market; some physicians would nonetheless prescribe it no matter dangers. . . . [A]ll physicians are completely different and procure their details about prescriptions from myriad sources. For these physicians with a mistrust of statements made by the pharmaceutical business, [defendant’s] statements couldn’t have been materials. . . . [P]hysicians take into account many patient-specific elements in figuring out which drug to prescribe, together with the affected person’s historical past and drug allergic reactions, the situation being handled, and the potential for hostile reactions with the affected person’s different drugs − along with the dangers and advantages related to the drug. When all of those patient-specific elements are part of the prescribing determination, the materiality of any statements made by [defendant] to any explicit prescribing determination can’t be presumed.
Id. at 98-99 (footnote omitted). None of those variations would have been related had the realized middleman rule not utilized. See additionally Weiss v. Astrazeneca Prescription drugs, 2010 WL 3387220 at *8-10 (Cal. App. Aug. 30, 2010) (similar end in unpublished Cal App. determination).
In Illinois, the “idea . . . generally known as the realized middleman doctrine” holds that “physicians act[] because the brokers for his or her sufferers in making the choice to make use of defendants’ merchandise.” Gredell v. Wyeth Laboratories, Inc., 2005 WL 4774219 at *44 (In poor health. Cir. June 10, 2005). Thus, a shopper safety plaintiff “was not in a position to exhibit that he, the affected person, was deceived by any act or omission of defendants,” which precluded causation beneath the Illinois statute. “[W]ithout a misleading act, apply, or omission and with out the harm or harm proximately brought on by that act, apply, or omission, plaintiff has not met his burden of proving shopper fraud.” Id. at *44-45. The intermediate Illinois appellate courtroom affirmed:
For the reason that [drugs] have been marketed to docs and pharmacists immediately, to not particular person customers, the alleged misrepresentations and/or omissions on [their] labels, packaging inserts and promoting supplies weren’t seen by the general public at giant. . . . If plaintiff by no means noticed the alleged misrepresentations, he can not have been deceived by them and any misrepresentation can not have proximately brought about him harm. The proof helps the courtroom’s discovering that plaintiff did not show his Client Fraud motion as a result of he did not show he suffered harm from defendants’ alleged misleading conduct or that this conduct proximately brought about his harm.
Gredell v. Wyeth Laboratories, Inc., 854 N.E.2nd 752, 757 (In poor health. App. 2006).
The realized middleman rule’s interruption of loss causation equally doomed a New Jersey shopper fraud declare:
[A]s a sensible matter, the merchandise stay obtainable solely by way of a doctor’s prescription. . . . [T]he intervention by a doctor within the decision-making course of necessitated by his or her train of judgment whether or not or to not prescribe a specific remedy protects customers in methods respecting efficacy which can be missing in promoting campaigns for different merchandise. On this context, that’s, inside a extremely regulated business during which the last word shopper will not be in reality free to behave on claims made in promoting in any occasion, the connection between phrases used within the promoting and buy of the product is at greatest an attenuated one.
New Jersey Citizen Motion v. Schering-Plough Corp., 842 A.2nd 174, 177-78 (New Jersey Tremendous. App. Div. 2003) (quotation omitted). See additionally Flynn v. American Residence Merchandise Corp., 627 N.W.2nd 342, 351-352 (Minn. App. 2001) (shopper safety declare fails for lack of proof, of doctor or plaintiff reliance); Golden v. Brown, 2017 WL 4239015 at *3 (Colo. Dist. Sept. 24, 2017) (realized middleman ideas precluded shopper safety claims); Baron v. Pfizer, Inc., 2006 WL 1623052, at *3 (in desk at 820 N.Y.S.2nd 841) (N.Y. Sup. Could 2, 2006) (“no allegations relating defendant’s alleged misleading apply of encouraging physicians to prescribe [the drug] for off-label use to plaintiff’s doctor prescribing [that drug] for plaintiff”), aff’d, 840 N.Y.S.2nd 445 (N.Y. App. Div. 2007); S.B. v. Ortho-McNeil-Janssen Prescription drugs, 2013 WL 3286808 at *24 (Pa. C.P. June 12, 2013) (“the existence of the LID makes it troublesome for a plaintiff to succeed on a UTPCPL declare in product legal responsibility litigation of prescribed drugs”); Albertson v. Wyeth, Inc., 63 D. & C.4th 514, 539 (Pa. C.P. 2003) (refusing to acknowledge direct-to-consumer exception to realized middleman rule that may permit shopper safety declare); Luke v. American Residence Merchandise Corp., 1998 WL 1781624 at *8 (Pa. C.P. Nov. 18, 1998) (similar).
There are lots of extra federal courtroom choices invoking the realized middleman rule to preclude shopper safety claims beneath the legal guidelines of varied states. In Schrott v. Bristol-Myers Squibb Co., 403 F.3d 940 (seventh Cir. 2005), abstract judgment in opposition to an Illinois shopper safety declare was affirmed the place the proof established:
that the package deal inserts for the [devices] disclosed the medically related dangers, that the medical group knew about these dangers, and that . . . the doctor who carried out the procedures . . . knew in regards to the dangers.
Id. at 944. Since “to maintain a reason behind motion beneath the Client Fraud Act, the plaintiffs should additional allege that damages have been proximately brought on by the fraud,” this unrebutted proof precluded showings of both materiality or causation. Id. at 944-45.
Because the Texas Supreme Court docket noticed in Hamilton, the Fifth Circuit had beforehand, and correctly, acknowledged the applicability of the realized middleman rule to the Texas shopper fraud statute:
We . . . make an Erie guess that the Texas Supreme Court docket would maintain that the realized middleman doctrine will not be a typical legislation protection however as a substitute a typical legislation doctrine . . ., that establishes the diploma to which a prescription drug producer is chargeable for an finish consumer’s reliance on the consequences of a prescription drug. As a result of we maintain that the realized middleman doctrine will not be a typical legislation protection . . ., [plaintiff’s] argument that the district courtroom incorrectly utilized it to the DTPA fails.
In re Norplant Contraceptive Merchandise Litigation, 165 F.3d 374, 377-78 (fifth Cir. 1999). Accord Rivera v. Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 n.7 (fifth Cir. 2002) (making use of Texas legislation) (noting applicability of realized middleman rule to Texas shopper safety claims).
A doctor was unable to say a Pennsylvania shopper safety declare in opposition to a medical gadget producer in Balderston v. Medtronic Sofamor Danek, Inc., 285 F.3d 238 (3d Cir. 2002), as a result of realized middleman ideas made clear that the physician “was neither the purchaser nor the patron of the [medical device].” Id. at 242.
[The physician] suggests his buy qualifies, as a result of he “bought” the [devices] for his sufferers’ “private use.” However now we have uncovered no Pennsylvania determination discovering actionable a non-representative plaintiff’s declare based mostly on others’ “private makes use of.” [The physician] employed the [devices] solely in his medical apply. His alleged losses weren’t “private,” however affected solely his medical apply.
Id.
A Connecticut shopper fraud declare was correctly dismissed in Vacationers Indemnity Co. v. Cephalon, Inc., 620 F. Appx. 82 (3d Cir. 2015)
[T]he allegations within the Amended Criticism fail to ascertain proximate trigger. Certainly, Plaintiffs didn’t allege that any physician relied on Defendants’ alleged misrepresentations in prescribing [the drugs], or that these prescriptions wouldn’t have been written if these physicians had not obtained the allegedly fraudulent data from [defendant]. Thus, Plaintiffs haven’t sufficiently pleaded causation , as required by CUTPA, and we are going to affirm the District Court docket’s dismissal of the CUTPA claims.
Id. at 87. See additionally Southeast Laborers Well being & Welfare Fund v. Bayer Corp., 444 F. Appx. 401, 408 (eleventh Cir. 2011) (“rel[iance] on the intermediaries of prescribing physicians” breaks the “causal nexus” of New Jersey shopper fraud declare).
A horde of federal district courtroom instances has utilized realized middleman ideas to state-law shopper fraud claims. We begin with these beneath the 4 states addressed by the MDL determination. We all know of six instances decoding California legislation. In Andren v. Alere, Inc., 2017 WL 6509550, at *22 (S.D. Cal. Dec. 20, 2017), the plaintiffs have been “affected person self-testers who have been prescribed their units by their healthcare suppliers” and in addition obtained “monitoring companies” from the defendant. Id. at *3. Individualized points created by the realized middleman rule defeated class actions certification.
Defendants have raised the protection of realized middleman arguing that the doctrine will not be amenable to class broad therapy because of the predominance of particular person questions. . . . As a result of the . . . merchandise have been prescribed medical units, in an effort to decide whether or not the realized middleman doctrine applies, individualized inquiries shall be required to find out whether or not Defendants knowledgeable the prescribing physicians and whether or not every treating doctor knew in regards to the dangers.
Id. at *23. See additionally Andren v. Alere, Inc., 207 F. Supp.3d 1133, 1144 (S.D. Cal. 2016) (“If [the product] was prescribed by a doctor, then the doctrine applies to [plaintiffs’] case and if that’s the case, Plaintiffs should correctly allege a failure to warn Plaintiffs’ prescribing doctor in an amended grievance.”) (footnote omitted).
Saavedra v. Eli Lilly & Co., 2013 WL 6345442, at *6 (C.D. Cal. Feb. 26, 2013), first decided that, whereas shopper fraud claims not completely barred by realized middleman rule, the rule’s applicability would possibly require abstract judgment on plaintiff-specific information) (making use of California, Massachusetts, Missouri, and New York legislation). Later, the identical courtroom concluded, “[e]very case that this Court docket has discovered, and that the events have recognized, that has particularly addressed the questions has discovered that the realized middleman doctrine applies to shopper safety claims predicated on a failure to warn.” Saavedra v. Eli Lilly & Co., 2013 WL 3148923, at *3 (C.D. Cal. June 13, 2013). See Utts v. Bristol-Myers Squibb Co., 251 F. Supp.3d 644, 683 n.32 (S.D.N.Y. 2017), aff’d, 919 F.3d 699 (2nd Cir. 2019) (following Saavedra to conclude that the realized middleman rule utilized to California shopper safety litigation); In re Yasmin & Yaz Advertising and marketing, Gross sales Practices & Merchandise Legal responsibility Litigation, 2012 WL 865041 at *20-21 (S.D. In poor health. March 13, 2012) (“Acquiring a prescription drug essentially entails a substantial interplay between the person affected person and his or her prescribing doctor.” Thus, “the numerous data conveyed by every prescribing doctor to putative class members prevents a discovering of uniformity” in a California shopper safety class motion).
Beale v. Biomet, Inc., 492 F. Supp.2nd 1360, 1372-1373 (S.D. Fla. 2007), adopted “federal courts in jurisdictions throughout the nation, together with Florida, . . . that the realized middleman doctrine encompasses all claims based mostly upon a pharmaceutical producer’s failure to warn, together with claims for fraud, misrepresentation, and violation of state shopper safety legal guidelines.” Id. at 1372.
The identical end result [as in Norplant] is warranted right here. Whereas Plaintiffs have supplied varied names for his or her claims . . ., the claims are all finally based mostly upon [defendant’s] alleged failure to warn of the dangers of the gadget. As a result of Florida has adopted the realized middleman doctrine, I conclude that it could comply with the reasoning above and maintain that the doctrine bars the Plaintiffs’ claims on this case.
Id. at 1373.
An Illinois shopper class motion failed for realized middleman causes in Dhamer v. Bristol-Myers Squibb Co., 183 F.R.D. 520, 531-532 (N.D. In poor health. 1998), due to the realized middleman rule requires individualized prescription choices, together with what data every affected person receives abut a prescription medical product.
[T]he doctor acts as a “realized middleman” between the producer and shopper. As a prescription medication, [the drug] will not be immediately marketed to the consuming affected person. Relatively, physicians are suggested in regards to the product [and] . . . decide whether or not or to not prescribe the medication to a specific affected person and what to inform the affected person. . . . Pharmacists may additionally make representations in regards to the product. Moreover, the knowledge obtainable to the medical group adjustments over time. . . . Thus, it’s doubtless that no two sufferers obtain precisely the identical data.
Id. at 531-32 (citations and footnote omitted). See In re Avandia Advertising and marketing, Gross sales Practices & Merchandise Legal responsibility Litigation, 2011 WL 4007858 at *2 (E.D. Pa. Sept. 7, 2011) (causation failed in Illinois shopper safety declare; “Plaintiff has not alleged that any misrepresentations have been communicated to him or to his prescribing doctor or that both of them relied upon the alleged misrepresentations”).
Thus, Maryland is the one one of many 4 states at challenge in Natera missing precedent holding particularly that the realized middleman rule applies to shopper safety claims. There’s a purpose for that. Prescription medical merchandise usually are not thought of “shopper” items in Maryland. See Hogan v. Maryland State Dental Assoc., 843 A.2nd 902, 906 (Md. Spec. App. 2004) (dental fillings not shopper items as a result of they “usually are not bought by customers as a very good however are chosen and utilized by a practitioner as a part of knowledgeable service”); Donalds v. Ethicon, Inc., 2021 WL 6126297, at *12 n.14 (D. Md. Dec. 28, 2021) (following Hogan).
Lastly, there are such a lot of federal district courtroom choices making use of realized middleman ideas within the context of different states’ shopper safety legal guidelines that we’ll merely checklist them right here.
Colorado: Curtin v. Ethicon, Inc., 2021 WL 825986, at *8 (D. Colo. March 4, 2021); Carver v. American Medical Techniques, Inc., 2020 WL 8258217, at *3 (D. Colo. Could 18, 2020).
Maine: Herzog v. Arthrocare Corp., 2003 WL 1785795 at *10 (D. Me. March 21, 2003).
Missouri: Foster v. Ethicon, Inc., 2021 WL 1700060, at *4 (W.D. Mo. March 31, 2021).
New Jersey: In re Avandia Advertising and marketing, Gross sales Practices & Merchandise Legal responsibility Litigation, 2011 WL 4007878, at *1 (E.D. Pa. Sept. 7, 2011) (making use of New Jersey legislation); Zafarana v Pfizer, Inc., 724 F. Supp.2nd 545, 556 (E.D. Pa. 2010) (making use of New Jersey legislation).
New York: Zottola v. Eisai, Inc., 564 F. Supp.3d 302, 312-13 (S.D.N.Y. 2021) (making use of New York legislation); Quintana v. B. Braun Medical Inc., 2018 WL 3559091, at *10 (S.D.N.Y. July 24, 2018); Becker v. Cephalon, Inc., 2015 WL 5472311, at *8 (S.D.N.Y. Sept. 15, 2015); Amos v. Biogen Idec, Inc., 28 F. Supp.3d 164, 173-74 (W.D.N.Y. 2014); Colacicco v. Apotex, Inc., 432 F. Supp.2nd 514, 549-50 (E.D. Pa. 2006), aff’d on different grounds, 521 F.3d 253 (3d Cir. 2008), vacated on different grounds, 556 U.S. 1101 (2009) (making use of New York legislation).
Pennsylvania: Cohen v. Johnson & Johnson, 634 F. Supp.3d 216, 232-33 (W.D. Pa. 2022); Brown v. C.R. Bard, Inc., 2022 WL 420914, at *7 (E.D. Pa. Feb. 11, 2022); Crockett v. Luitpold Prescription drugs, Inc., 2020 WL 433367, at *9 (E.D. Pa. Jan. 28, 2020); Wallace v. Boston Scientific Corp., 2018 WL 6981220, at *9 n.6 (Magazine. M.D. Pa. Nov. 29, 2018), adopted, 2019 WL 137605 (M.D. Pa. Jan. 8, 2019); McLaughlin v. Bayer Corp., 172 F. Supp.3d 804, 831-32 (E.D. Pa. 2016); White v. Medtronic, Inc., 2016 WL 4539494, at *3 (E.D. Pa. Aug. 31, 2016); Stout v. Superior Bionics, LLC, 2013 WL 12133966, at *9 (W.D. Pa. Sept. 19, 2013); In re Avandia Advertising and marketing, Gross sales Practices & Merchandise Legal responsibility Litigation, 2013 WL 3486907, at *2 (E.D. Pa. July 10, 2013); Kee v. Zimmer, Inc., 871 F. Supp.2nd 405, 411 (E.D. Pa. 2012); In re Avandia Advertising and marketing, Gross sales Practices & Merchandise Legal responsibility Litigation, 2011 WL 4006639, at *2 (E.D. Pa. Sept. 7, 2011); Zafarana v Pfizer, Inc., 724 F. Supp.2nd 545, 558 (E.D. Pa. 2010); Kester v. Zimmer Holdings, Inc., 2010 WL 2696467, at *14 (W.D. Pa. June 16, 2010); Smith v. Bristol-Myers Squibb Co., 2009 WL 5216982, at *5-6 (D.N.J. Dec. 30, 2009) (making use of Pennsylvania legislation); Heindel v. Pfizer, Inc., 381 F. Supp.2nd 364, 384 (D.N.J. 2004) (making use of Pennsylvania legislation).
South Carolina: Carnes v. Eli Lilly & Co., 2013 WL 6622915, at *3 & n.2 (D.S.C. Dec. 16, 2013).
Texas: Gomez v. ALN Worldwide, Inc., 2022 WL 6468725, at *6-7 (S.D. Tex. Oct. 10, 2022); Gutierrez v. Ethicon, Inc., 535 F. Supp.3d 608, 633-34 (W. D. Tex. 2021); Perez v. American Medical Techniques, Inc., 461 F. Supp.3d 488, 507-08 (W.D. Tex. 2020); Marrufo v. Ethicon, Inc., 2020 WL 7680562, at *3-4 (W.D. Tex. Nov. 20, 2020); Casey v. Bristol-Myers Squibb Co., 2018 WL 8545854, at *2 (W.D. Tex. April 20, 2018), aff’d, 741 F. Appx. 243 (fifth Cir. 2018); Gonzalez v. Bayer Healthcare Prescription drugs, Inc., 930 F. Supp.2nd 808, 814 (S.D. Tex. 2013) (making use of Texas legislation); Johnson v. Medtronic, Inc., 2005 WL 1515402, at *3 (S.D. Tex. June 23, 2005) (making use of Texas legislation); Dyer v. Danek Medical, Inc., 115 F. Supp.2nd 732, 740-41 (N.D. Tex. 2000) (making use of Texas legislation); In re Norplant Contraceptive Merchandise Litigation, 955 F. Supp. 700, 709 (E.D. Tex. 1997), aff’d, 165 F.3d 374, 377-378 (fifth Cir. 1999).
Utah: In re Avandia Advertising and marketing, Gross sales Practices & Merchandise Legal responsibility Litigation, 286 F. Supp.3d 667, 674 (E.D. Pa. 2017), aff’d, 746 F. Appx. 122 (3d Cir. 2018) (making use of Utah legislation).
Wisconsin: Valente v. Sofamor, S.N.C., 48 F. Supp.2nd 862, 873 (E.D. Wis. 1999).
In sum, we’ve had it with federal district courts, significantly in multi-district litigation, ignoring the Supreme Court docket’s – and related circuit courtroom – prohibitions in opposition to expansive predictions of state legislation in range jurisdiction instances. Defendants would not have the burden of disproving each attainable concept of legal responsibility that plaintiffs can invent. Relatively, plaintiffs have the duty to exhibit affirmatively that the related state’s excessive courtroom would doubtless undertake any given concept. If there is no such thing as a legislation, then federal courts are with out energy to create new state-law theories of tort legal responsibility.